Blood levels of two insulin-related proteins are able to predict which patients with colon cancer are most likely to die of their disease by 87%, new research suggests.
Read More »Arena Pharmaceuticals Announces First In Class Treatment for Type 2 Diabetes Begins Phase 1 Trial
Phase 1 clinical trial of APD597, a novel first in class oral drug candidate that targets the glucose-dependent insulinotropic receptor (GDIR) for the treatment of type 2 diabetes will begin shortly. The GDIR has the potential to stimulate insulin release in response to increases in blood glucose. Ortho-McNeil-Janssen Pharmaceuticals will be …
Read More »Diabetic Binge Eaters Can Still Lose Weight
The success of weight-loss in overweight and obese individuals with type 2 diabetes is not affected by a history of binge eating, according to a report in the Archives of General Psychiatry.
Read More »Chromosome Linked to Diabetics’ Heart Risks
Adding to earlier research, a new study has identified a genetic variation that increases the risk of coronary artery disease (CAD) in type 2 diabetes patients with poor sugar glucose (glycemic) control.
Read More »Aggressive Cholesterol Lowering Has Benefits For Type 2’s
In people with type 2 diabetes, intensive drug therapy to significantly lower “bad” LDL cholesterol reduces the thickness of the carotid arteries, the major arteries in the neck that supply oxygen to the brain, research shows.
Read More »How Important is Blood Glucose Variability In The Management Of Type 2 Diabetes?
A group of researchers conducted a study to investigate the role of blood glucose (BG) variability in glycemic control in patients with type 2 diabetes.
Read More »No-Carb Diets May Impair Memory
Memory improved when carbs reintroduced to diet. Eliminating carbohydrates from your diet may help you lose weight, but it could leave you fuzzy headed and forgetful, a new study suggests.
Read More »Continuous Blood Pressure Monitoring, A Predictor of Future Heart Events
In the largest study of its kind to date, researchers have shown that continually monitoring blood pressure (BP) — called ambulatory BP monitoring (ABPM) — is a predictor of future cardiovascular events in patients with resistant hypertension, but office BP is not .
Read More »Change at the FDA
David Kliff, Publisher, Diabetic Investor, has been looking at the President-elect’s recent appointments and keeps wondering who will be the new head the Food and Drug Administration. Whoever it is will have an interesting road ahead of them.
Read More »Why How Much Insulin You Have “on Board” during Exercise Matters
More and more of our patients using insulin are exercising and participating in sports. They often lower their basal rates or decrease their mealtime dose to try and compensate. This can lead to hyperglycemia or hypoglycemia after exercising. Why does that happen and what changes over time. Dr. Sheri Colberg, …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.